Drug profile · INN
vasopressin
VASOPRESSIN
- US status
- approved
- Patents linked
- 7
- News articles
- 0
Quick answer
vasopressin (VASOPRESSIN) is an FDA-listed pharmaceutical active ingredient. Associated with Regeneron Ireland Designated Activity Company (DAC). Route of administration: injection. Current US regulatory status: approved.
Key facts
Related patents
Search patents →-
US 12247037
1-(2,6-diazaspiro[3.3]heptan-6-yl)-5,6-dihydro-4h-benzo[f][1,2,4]triazolo[4,3-A][1,4]diazepine derivatives and related compounds as vasopressin antagonists for the treatment of neuro-psychological disorders
granted -
US 12152038
Vasopressin receptor antagonists and products and methods related thereto
granted -
US 11858943
Vasopressin receptor antagonists and products and methods related thereto
granted -
US 11186577
Vasopressin receptor antagonists and products and methods related thereto
granted -
US 10538530
Vasopressin receptor antagonists and products and methods related thereto
granted -
US 10172911
Methods of modulating erythropoiesis with arginine vasopressin receptor 1B molecules
granted -
US 9631001
Peptide antagonists of the vasopressin-2 receptor
granted
Frequently asked questions
What is vasopressin?
vasopressin (VASOPRESSIN) is an FDA-listed pharmaceutical active ingredient. Associated with Regeneron Ireland Designated Activity Company (DAC). Route of administration: injection. Current US regulatory status: approved.
What is the brand name for vasopressin?
VASOPRESSIN is a marketed brand name for vasopressin. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of vasopressin?
vasopressin has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.